Amy J. Mathers

9.6k total citations · 7 hit papers
101 papers, 5.5k citations indexed

About

Amy J. Mathers is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry. According to data from OpenAlex, Amy J. Mathers has authored 101 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Medicine, 34 papers in Endocrinology and 31 papers in Clinical Biochemistry. Recurrent topics in Amy J. Mathers's work include Antibiotic Resistance in Bacteria (68 papers), Bacterial Identification and Susceptibility Testing (31 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Amy J. Mathers is often cited by papers focused on Antibiotic Resistance in Bacteria (68 papers), Bacterial Identification and Susceptibility Testing (31 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Amy J. Mathers collaborates with scholars based in United States, United Kingdom and Canada. Amy J. Mathers's co-authors include Pranita D. Tamma, Robert A. Bonomo, David van Duin, Cornelius J. Clancy, Samuel L Aitken, Johann Pitout, Gisele Peirano, Costi D. Sifri, Derrick W. Crook and Nicole Stoesser and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Applied and Environmental Microbiology.

In The Last Decade

Amy J. Mathers

98 papers receiving 5.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae

2015 609 citations Amy J. Mathers, Gisele Peirano et al. profile →
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

2023 402 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfections

2021 333 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

2024 328 citations Pranita D. Tamma, Emily L. Heil et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2020 310 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2022 308 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), andPseudomonas aeruginosawith Difficult-to-Treat Resistance (DTR-P. aeruginosa)

2021 303 citations Pranita D. Tamma, Robert A. Bonomo et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Amy J. Mathers

Since Specialization

Citations

This map shows the geographic impact of Amy J. Mathers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy J. Mathers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy J. Mathers more than expected).

Fields of papers citing papers by Amy J. Mathers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy J. Mathers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy J. Mathers. The network helps show where Amy J. Mathers may publish in the future.

Co-authorship network of co-authors of Amy J. Mathers

This figure shows the co-authorship network connecting the top 25 collaborators of Amy J. Mathers. A scholar is included among the top collaborators of Amy J. Mathers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy J. Mathers. Amy J. Mathers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Timing Is Everything: Recognizing the Importance of Infusion Duration in Preoperative Antimicrobial Prophylaxis 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Traci L. Hedrick, Amy J. Mathers	0
2	Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections breakdown → 2024 ·Clinical Infectious Diseases ·Pranita D. Tamma, Emily L. Heil, Julie Ann Justo, Amy J. Mathers, Michael J. Satlin, Robert A Bonomo	328
3	A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance 2024 ·Antimicrobial Agents and Chemotherapy ·Jeffrey A. Freiberg, Lili Tao, (unknown), Laura A. Mike, George E. Nelson, Bryan Harris, Amy J. Mathers, Thomas R. Talbot, Eric P. Skaar, Romney M. Humphries	5
4	Evaluation of Piperacillin-Tazobactam Testing against Enterobacterales by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints 2023 ·Journal of Clinical Microbiology ·(unknown), (unknown), April N. Abbott, (unknown), Kevin Alby, (unknown), Jennifer Dien Bard, (unknown), (unknown), Amanda Harrington, (unknown), Amy J. Mathers, Tsigereda Tekle, Patricia J. Simner, Romney M. Humphries	9
5	Some like it hot: Variable impact of a tailpiece heating device on different gram-negative bacteria 2023 ·SHILAP Revista de lepidopterología ·Stacy Park, Shireen Kotay, Katie E. Barry, Joanne Carroll, (unknown), William H. Guilford, Amy J. Mathers	2
6	137. Penicillin (PCN) Gradient Diffusion Overcalls Resistance and Promotes Unnecessary Vancomycin (VAN) Use in Enterococcus faecalis Bloodstream Infections (BSI) 2023 ·Open Forum Infectious Diseases ·(unknown), Heather L. Cox, (unknown), (unknown), (unknown), Amy J. Mathers	1
7	Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant 2023 ·Open Forum Infectious Diseases ·Alice J. Hsu, Patricia J. Simner, Yehudit Bergman, Amy J. Mathers, Pranita D. Tamma	12
8	Building-Level Wastewater Surveillance for SARS-CoV-2 in Occupied University Dormitories as an Outbreak Forecasting Tool: One Year Case Study 2022 ·ACS ES&T Water ·Shireen Kotay, Kawai O. Tanabe, Lisa M. Colosi, Melinda D. Poulter, (unknown), Christopher P. Holstege, Amy J. Mathers, Michael D. Porter	12
9	Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales 2022 ·Clinical Infectious Diseases ·Pranita D. Tamma, Patrick N. A. Harris, Amy J. Mathers, Eric Wenzler, Romney M. Humphries	22
10	Clinical challenges treatingStenotrophomonas maltophiliainfections: an update 2022 ·JAC-Antimicrobial Resistance ·María F. Mojica, Romney M. Humphries, John J. LiPuma, Amy J. Mathers, Gauri G. Rao, Samuel A. Shelburne, Derrick E. Fouts, David van Duin, Robert A. Bonomo	72
11	Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial 2022 ·Open Forum Infectious Diseases ·(unknown), Alexandra N. Donlan, Z. Jennie, Heather M. Haughey, (unknown), Uma Nayak, Amy J. Mathers, Sylvain Laverdure, Robin Dewar, Patrick Jackson, Scott K. Heysell, Jeffrey M. Sturek, William A. Petri	19
12	Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients 2020 ·Microbial Genomics ·Bede Constantinides, Kevin Chau, T. Phuong Quan, Gillian Rodger, Monique Andersson, Katie Jeffery, Samuel Lipworth, Hyun S. Gweon, Andy Peniket, (unknown), (unknown), (unknown), (unknown), (unknown), Amy J. Mathers, Derrick W. Crook, Tim Peto, A. Sarah Walker, Nicole Stoesser	37
13	The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates 2019 ·Journal of Clinical Microbiology ·(unknown), Katie E. Barry, Heather L. Cox, Nicole Stoesser, Joanne Carroll, Kasi Vegesana, Shireen Kotay, Anna E. Sheppard, Alexander M. Wailan, Derrick W. Crook, Hardik I. Parikh, Amy J. Mathers	30
14	Don't overlook the little guy: An evaluation of the frequency of small plasmids co-conjugating with larger carbapenemase gene containing plasmids 2019 ·Plasmid ·Katie E. Barry, Alexander M. Wailan, Anna E. Sheppard, Derrick W. Crook, Kasi Vegesana, Nicole Stoesser, Hardik I. Parikh, Robert Sebra, Amy J. Mathers	33
15	TETyper: a bioinformatic pipeline for classifying variation and genetic contexts of transposable elements from short-read whole-genome sequencing data 2018 ·Microbial Genomics ·Anna E. Sheppard, Nicole Stoesser, (unknown), Kasi Vegesana, A Sarah Walker, Derrick W. Crook, Amy J. Mathers	29
16	The effect of rapid diagnostic testing with Infectious Diseases fellow consultative intervention on the management of enterococcal bloodstream infection 2018 ·Diagnostic Microbiology and Infectious Disease ·Megan Gray, Heather L. Cox, (unknown), Melinda D. Poulter, Joshua C. Eby, Amy J. Mathers	3
17	Spread from the Sink to the Patient: In Situ Study Using Green Fluorescent Protein (GFP)-Expressing Escherichia coli To Model Bacterial Dispersion from Hand-Washing Sink-Trap Reservoirs 2017 ·Applied and Environmental Microbiology ·Shireen Kotay, Weidong Chai, William H. Guilford, Katie E. Barry, Amy J. Mathers	140
18	Escherichia coli ST131: The Quintessential Example of an International Multiresistant High-Risk Clone 2014 ·Advances in applied microbiology ·Amy J. Mathers, Gisele Peirano, Johann Pitout	109
19	Genotypic Diversity of an Emergent Population of Borrelia burgdorferi at a Coastal Maine Island Recently Colonized by Ixodes scapularis 2012 ·Vector-Borne and Zoonotic Diseases ·(unknown), Charles Lubelczyk, Susan P. Elias, (unknown), Amy J. Mathers, Eleanor H. Lacombe, Peter W. Rand, Robert P. Smith	11
20	Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid 2011 ·mBio ·Amy J. Mathers, Heather L. Cox, Brandon Kitchel, Hugo Bonatti, Ann Karen C. Brassinga, Joanne Carroll, W. Michael Scheld, Kevin C. Hazen, Costi D. Sifri	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact